These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9431921)

  • 1. Evaluation of a new method for rapid drug susceptibility testing of Mycobacterium avium complex isolates by using the mycobacteria growth indicator tube.
    Piersimoni C; Nista D; Bornigia S; De Sio G
    J Clin Microbiol; 1998 Jan; 36(1):64-7. PubMed ID: 9431921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs.
    Krishnan MY; Manning EJ; Collins MT
    J Antimicrob Chemother; 2009 Aug; 64(2):310-6. PubMed ID: 19457932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the mycobacteria growth indicator tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs.
    Rüsch-Gerdes S; Domehl C; Nardi G; Gismondo MR; Welscher HM; Pfyffer GE
    J Clin Microbiol; 1999 Jan; 37(1):45-8. PubMed ID: 9854062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.
    Bemer P; Palicova F; Rüsch-Gerdes S; Drugeon HB; Pfyffer GE
    J Clin Microbiol; 2002 Jan; 40(1):150-4. PubMed ID: 11773109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of potassium tellurite for rapid-drug susceptibility testing of Mycobacterium avium complex.
    Afghani B; Fujiyama D
    J Investig Med; 2001 May; 49(3):292-6. PubMed ID: 11352188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
    Ardito F; Posteraro B; Sanguinetti M; Zanetti S; Fadda G
    J Clin Microbiol; 2001 Dec; 39(12):4440-4. PubMed ID: 11724858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
    Vanitha JD; Paramasivan CN
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):179-82. PubMed ID: 15246507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Bergmann JS; Woods GL
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
    Rastogi N; Goh KS; Bryskier A
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1433-8. PubMed ID: 8092850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.
    Fattorini L; Li B; Piersimoni C; Tortoli E; Xiao Y; Santoro C; Ricci ML; Orefici G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):680-5. PubMed ID: 7793873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Talbot JA; Chomyc S; Davison E; Singer J; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG
    Clin Infect Dis; 1998 Dec; 27(6):1401-5. PubMed ID: 9868650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid drug susceptibility of Mycobacterium avium complex using a fluorescence quenching method.
    Marone P; Bono L; Carretto E; Barbarini D; Telecco S
    J Chemother; 1997 Aug; 9(4):247-50. PubMed ID: 9269603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
    Reisner BS; Gatson AM; Woods GL
    Diagn Microbiol Infect Dis; 1995 Aug; 22(4):325-9. PubMed ID: 8582137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens.
    Cho EH; Huh HJ; Song DJ; Moon SM; Lee SH; Shin SY; Kim CK; Ki CS; Koh WJ; Lee NY
    J Infect Chemother; 2018 Apr; 24(4):315-318. PubMed ID: 29223615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis.
    Ardito F; Sanguinetti M; Sechi L; Posteraro B; Masucci L; Fadda G; Zanetti S
    New Microbiol; 2000 Apr; 23(2):151-8. PubMed ID: 10872685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid susceptibility testing of Mycobacterium tuberculosis by the Mycobacteria Growth Indicator Tube (MGIT AST SIRE).
    Macondo EA; Ba F; Gaye-Diallo A; Touré-Kane NC; Kaïré O; Gueye-Ndiaye A; Boye CS; Mboup S
    Clin Microbiol Infect; 2000 Jul; 6(7):363-7. PubMed ID: 11168152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug susceptibility distributions in slowly growing non-tuberculous mycobacteria using MGIT 960 TB eXiST.
    Hombach M; Somoskövi A; Hömke R; Ritter C; Böttger EC
    Int J Med Microbiol; 2013 Jul; 303(5):270-6. PubMed ID: 23689069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis.
    Adjers-Koskela K; Katila ML
    J Clin Microbiol; 2003 Mar; 41(3):1235-9. PubMed ID: 12624056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
    Rastogi N; Goh KS; Bryskier A; Devallois A
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2483-7. PubMed ID: 8913450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.